Zobrazeno 1 - 10
of 21
pro vyhledávání: '"Júlia Teixeira Cottas de Azevedo"'
Autor:
Virgínia Picanço-Castro, Pablo Diego Moço, Amanda Mizukami, Leticia Delfini Vaz, Marcelo de Souza Fernandes Pereira, Renata Nacasaki Silvestre, Júlia Teixeira Cottas de Azevedo, Aline de Sousa Bomfim, Mario Soares de Abreu Neto, Kelen Cristina Ribeiro Malmegrim, Kamilla Swiech, Dimas Tadeu Covas
Publikováno v:
Hematology, Transfusion and Cell Therapy, Vol 42, Iss 2, Pp 150-158 (2020)
Introduction: Adoptive transfer of T cells expressing a CD19-specific chimeric antigen receptor (CAR) has shown impressive response rates for the treatment of CD19 + B-cell malignancies in numerous clinical trials. The CAR molecule, which recognizes
Externí odkaz:
https://doaj.org/article/46b2df83e5f24db88e2dd8999c65cfb5
Autor:
Luciana Ribeiro Jarduli‐Maciel, Júlia Teixeira Cottas de Azevedo, Emmanuel Clave, Thalita Cristina de Mello Costa, Lucas Coelho Marlière Arruda, Isabelle Fournier, Patrícia Vianna Bonini Palma, Keli Cristina Lima, Juliana Bernardes Elias, Ana Beatriz PL Stracieri, Fabiano Pieroni, Renato Cunha, Luiz Guilherme Darrigo‐Júnior, Carlos Eduardo Settani Grecco, Dimas Tadeu Covas, Ana Cristina Silva‐Pinto, Gil Cunha De Santis, Belinda Pinto Simões, Maria Carolina Oliveira, Antoine Toubert, Kelen Cristina Ribeiro Malmegrim
Publikováno v:
Clinical & Translational Immunology, Vol 11, Iss 4, Pp n/a-n/a (2022)
Abstract Objectives Allogeneic haematopoietic stem cell transplantation (allo‐HSCT) is the only currently available curative treatment for sickle cell disease (SCD). Here, we comprehensively evaluated the reconstitution of T‐ and B‐cell compart
Externí odkaz:
https://doaj.org/article/c781cf229ea44de68805e00caa2a983d
Autor:
Júlia Teixeira Cottas de Azevedo, Thalita Cristina de Mello Costa, Keli Cristina Lima, Thiago Trovati Maciel, Patrícia Vianna Bonini Palma, Luiz Guilherme Darrigo-Júnior, Carlos Eduardo Setanni Grecco, Ana Beatriz P. L. Stracieri, Juliana Bernardes Elias, Fabiano Pieroni, Renato Luiz Guerino-Cunha, Ana Cristina Silva Pinto, Gil Cunha De Santis, Dimas Tadeu Covas, Olivier Hermine, Belinda Pinto Simões, Maria Carolina Oliveira, Kelen Cristina Ribeiro Malmegrim
Publikováno v:
Frontiers in Immunology, Vol 12 (2021)
Allogeneic hematopoietic stem cell transplantation (allo-HSCT) is the only currently available curative treatment for sickle cell disease (SCD). However, the effects of HSCT on SCD pathophysiology are poorly elucidated. Here, we assessed red blood ce
Externí odkaz:
https://doaj.org/article/0f750815091a46f1913f64b81244f2f3
Autor:
Kelen Cristina Ribeiro Malmegrim, João Rodrigues Lima-Júnior, Lucas Coelho Marlière Arruda, Júlia Teixeira Cottas de Azevedo, Gislane Lelis Vilela de Oliveira, Maria Carolina Oliveira
Publikováno v:
Frontiers in Immunology, Vol 9 (2018)
Phase I/II clinical trials of autologous hematopoietic stem cell transplantation (AHSCT) have led to increased safety and efficacy of this therapy for severe and refractory autoimmune diseases (AD). Recent phase III randomized studies have demonstrat
Externí odkaz:
https://doaj.org/article/ca468fb767614137bf2be010c45b5045
Publikováno v:
Biblioteca Digital de Teses e Dissertações da USPUniversidade de São PauloUSP.
O diabetes mellitus tipo 1 (DM-1) é uma doença autoimune órgão-específica caracterizada pela destruição seletiva das células pancreáticas produtoras de insulina. A imunossupressão em altas doses seguida do transplante autólogo de células-
Autor:
Dayane Schmidt, Sima Ebrahimabadi, Kauan Ribeiro de Sena Gomes, Graziela de Moura Aguiar, Mariane Cariati Tirapelle, Renata Nacasaki Silvestre, Júlia Teixeira Cottas de Azevedo, Dimas Tadeu Covas, Virginia Picanço-Castro
Publikováno v:
Immunotherapy Advances. 2
Cell therapy is an innovative approach that permits numerous possibilities in the field of cancer treatment. CAR-T cells have been successfully used in patients with hematologic relapsed/refractory. However, the need for autologous sources for T cell
Autor:
V.P.E. Castro, Kamilla Swiech, Kelen C. R. Malmegrim, K.R.S. Gomes, Júlia Teixeira Cottas de Azevedo, Dimas Tadeu Covas, Renata Nacasaki Silvestre
Publikováno v:
Hematology, Transfusion and Cell Therapy, Vol 42, Iss, Pp 420-(2020)
Publikováno v:
Repositório Institucional da USP (Biblioteca Digital da Produção Intelectual)
Universidade de São Paulo (USP)
instacron:USP
Universidade de São Paulo (USP)
instacron:USP
Sickle cell disease (SCD) is caused by a single point mutation in the β-chain of the hemoglobin gene that results in the replacement of glutamic acid with valine in the hemoglobin protein. However, recent studies have demonstrated that alterations i
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0b75cf1904b12678b54c53a0b3c05086
Autor:
Kamilla Swiech, Aline de Sousa Bomfim, Amanda Mizukami, Renata Nacasaki Silvestre, Marcelo S. F. Pereira, Leticia Delfini Vaz, Pablo Diego Moço, Dimas Tadeu Covas, Júlia Teixeira Cottas de Azevedo, Mario Soares de Abreu Neto, Virgínia Picanço-Castro, Kelen C. R. Malmegrim
Publikováno v:
Repositório Institucional da USP (Biblioteca Digital da Produção Intelectual)
Universidade de São Paulo (USP)
instacron:USP
Hematology, Transfusion and Cell Therapy
Hematology, Transfusion and Cell Therapy, Vol 42, Iss 2, Pp 150-158 (2020)
Universidade de São Paulo (USP)
instacron:USP
Hematology, Transfusion and Cell Therapy
Hematology, Transfusion and Cell Therapy, Vol 42, Iss 2, Pp 150-158 (2020)
Introduction Adoptive transfer of T cells expressing a CD19-specific chimeric antigen receptor (CAR) has shown impressive response rates for the treatment of CD19 + B-cell malignancies in numerous clinical trials. The CAR molecule, which recognizes c
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::def046d16d6a1ff5b8e3533cb2aafdbb
Autor:
Dimas Tadeu Covas, Virgínia Picanço-Castro, Kelen C. R. Malmegrim, Júlia Teixeira Cottas de Azevedo, A.M. Pessoni, Renata Nacasaki Silvestre
Publikováno v:
Hematology, Transfusion and Cell Therapy, Vol 42, Iss, Pp 422-423 (2020)